Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.840
+0.010 (0.21%)
At close: Apr 28, 2026, 4:00 PM EDT
4.840
0.00 (0.00%)
Pre-market: Apr 29, 2026, 7:57 AM EDT

Myriad Genetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
4575731,2481,6971,1762,204
Upgrade
Market Cap Growth
-37.03%-54.07%-26.46%44.34%-46.65%48.19%
Upgrade
Enterprise Value
5176401,2911,8121,0541,884
Upgrade
Last Close Price
4.846.1513.7119.1414.5127.60
Upgrade
Forward PE
102.78196.49141.34---
Upgrade
PS Ratio
0.550.701.492.251.733.19
Upgrade
PB Ratio
1.231.561.782.171.332.28
Upgrade
P/TBV Ratio
2.803.528.1911.985.546.94
Upgrade
P/FCF Ratio
-----3673.31
Upgrade
P/OCF Ratio
253.95318.48---118.49
Upgrade
EV/Sales Ratio
0.630.781.542.411.552.73
Upgrade
EV/FCF Ratio
-----3139.65
Upgrade
Debt / Equity Ratio
0.570.570.200.190.160.10
Upgrade
Debt / EBITDA Ratio
65.5665.56----
Upgrade
Debt / FCF Ratio
-----153.83
Upgrade
Net Debt / Equity Ratio
0.160.160.050.01-0.03-0.32
Upgrade
Net Debt / EBITDA Ratio
-4.27-4.27-1.41-0.130.354.78
Upgrade
Net Debt / FCF Ratio
-4.36-4.36-1.37-0.060.16-509.17
Upgrade
Asset Turnover
0.950.950.770.640.540.50
Upgrade
Inventory Turnover
8.538.5310.1911.2211.419.32
Upgrade
Quick Ratio
1.981.981.361.641.582.11
Upgrade
Current Ratio
2.492.491.822.012.002.37
Upgrade
Return on Equity (ROE)
-68.45%-68.45%-17.15%-31.55%-12.08%-2.94%
Upgrade
Return on Assets (ROA)
-4.89%-4.89%-5.06%-7.71%-6.14%-5.78%
Upgrade
Return on Invested Capital (ROIC)
-15.62%-11.62%-11.48%-16.91%-15.11%-14.56%
Upgrade
Return on Capital Employed (ROCE)
-11.80%-11.80%-10.20%-14.60%-11.70%-11.30%
Upgrade
Earnings Yield
-80.05%-63.83%-10.20%-15.52%-9.53%-1.23%
Upgrade
FCF Yield
-3.02%-2.41%-2.22%-10.26%-12.89%0.03%
Upgrade
Buyback Yield / Dilution
-2.21%-2.21%-9.42%-2.73%-3.33%-4.31%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.